Pharmaceutical firm’s compliance program for fair trade loses momentum

Efforts of pharmaceutical companies for self-purification to root out illicit practices have lost its early momentum in the face of prevailing irregular business practices, according to pharmaceutical business sources.

One of the things drug makers are famous for is their world of rebates, money given to hospitals and other medical institutions in exchange for a secure distribution channel.
...